![]() | License: Creative Commons Attribution 4.0 PDF - Accepted Version (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-530105
- DOI to cite this document:
- 10.5283/epub.53010
Abstract
Overexpression of the neurotensin receptor type 1 (NTS1R), a peptide receptor located at the plasma membrane, has been reported for a variety of malignant tumors. Thus, targeting the NTS1R with 18F- or 68Ga-labeled ligands is considered a straightforward approach towards in vivo imaging of NTS1R-expressing tumors via positron emission tomography (PET). The development of suitable peptidic NTS1R ...

Owner only: item control page